Nasal HFOV Versus Nasal SIPPV in Neonate Following Extubation: RCT Crossover Study

NACompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

August 1, 2022

Conditions
High-Frequency VentilationIntermittent Positive-Pressure VentilationNewborn MorbidityNoninvasive Ventilation
Interventions
DEVICE

Non-invasive ventilation

Intervention nasal high frequency oscillatory ventilation (nHFOV) and nasal synchronized intermittent positive pressure ventilation (nSIPPV) were generated by neonatal ventilators (SLE6000 infant ventilators, United Kingdom) using bi-nasal prongs (RAM cannula, NEOTECH®, USA) or the nasal mask of the same type for both ventilation modes. The size of the prongs was determined by the infant's weight. The largest possible prongs were used, with a snug fit to avoid leakage. Pacifier for preterm and term neonate (Jollypop™, USA) was taken to avoid leakage from the mouth. The disposable ventilator circuit (Fisher \& Paykel RT268™, Evaqua Dual Limb Infant Breathing Circuit Kit with Evaqua 2 Technology and Pressure Line, Flow \> 4L/min, New Zealand) was used. The initial NIV setting was (7) described in arm description. (above)

Trial Locations (1)

90110

Songklanagarind Hospital, Prince of Songkla University, Hat Yai

All Listed Sponsors
lead

Prince of Songkla University

OTHER

NCT04323397 - Nasal HFOV Versus Nasal SIPPV in Neonate Following Extubation: RCT Crossover Study | Biotech Hunter | Biotech Hunter